2011
DOI: 10.1016/j.actbio.2011.04.024
|View full text |Cite
|
Sign up to set email alerts
|

A novel hydrogel-collagen composite improves functionality of an injectable extracellular matrix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
54
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 44 publications
(57 citation statements)
references
References 44 publications
3
54
0
Order By: Relevance
“…19,20 The immunostaining confirmed IDO expression in fibroblasts within the matrix while majority of fibroblasts remained viable. 9,10 We found that the alloantigen specific proliferation of splenocytes was remarkably suppressed in the presence of Lenti-IDO fibroblast-mediated environment; this effect was partially restored by the addition of 1-MT, an IDO inhibitor, indicating that the observed suppressive effect was due to IDO activity.…”
Section: Discussionmentioning
confidence: 83%
See 2 more Smart Citations
“…19,20 The immunostaining confirmed IDO expression in fibroblasts within the matrix while majority of fibroblasts remained viable. 9,10 We found that the alloantigen specific proliferation of splenocytes was remarkably suppressed in the presence of Lenti-IDO fibroblast-mediated environment; this effect was partially restored by the addition of 1-MT, an IDO inhibitor, indicating that the observed suppressive effect was due to IDO activity.…”
Section: Discussionmentioning
confidence: 83%
“…7 However, the FPCM was prone to gradual biodegradation and contraction, negatively affecting the long-term survival and function of the islets. 9 Recently, we developed a novel bioengineered, cross-linked collagen-glycosaminoglycan matrix (CCM). 9,10 When populated by fibroblasts (FP-CCM), it provided enhanced mechanical strength and reduced contraction both in vitro and in vivo in a mouse model of syngeneic ICT.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Collagen type I scaffold formulations have included sponges, [25][26][27][28][29][30][31][32][33] fibers, 19,34,35 hydrogels, [36][37][38][39][40][41][42][43] and microspheres. 44 51 To address limitations associated with collagen, researchers have often chosen to use different crosslinking agents and/or composites of collagen with other materials.…”
Section: Collagen Type Imentioning
confidence: 99%
“…For example, scaffolds of type I collagen and chondroitin-6-sulfate, termed in the literature more generally as collagen-GAG or CG scaffolds, represent a common raw material blend for bone, 46 cartilage, 53,54 tendon, 47 and skin 38,55,56 tissue engineering. One particularly innovative raw material technique used a CG core-shell fabrication strategy to enhance mechanical integrity while maintaining a highly porous structure.…”
mentioning
confidence: 99%